Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
222 participants
OBSERVATIONAL
2022-07-12
2025-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The secondary aim is to evaluate the relationship between the concentrations of endocrine disruptors and some anamnestic variables studied (for example the type of diet, the use of personal care products).
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Impact of Conventional Treatments and Clinical Variables on Thyroid Cancer
NCT05752604
The Effect of Thyroid Hormone on Drug Elimination in Cancer Patients
NCT00080574
Phase 4 Study in Secondary Hypothyroidism: Body Weight Adapted Thyroxin Treatment and Triiodothyronine Supplementation
NCT00360074
Decitabine in Treating Patients With Metastatic Papillary Thyroid Cancer or Follicular Thyroid Cancer Unresponsive to Iodine I 131
NCT00085293
Study of Clinical Outcomes of Thyroid Cancer
NCT04031339
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Case group
Patients with thyroid cancer diagnosis within 5 years before study enrollment
Blood and urine diagnostic evaluation
Blood and urine samples will be obtained from both case and control groups in order to evaluate EDCs concentrations
Control group
Patients without clinical diagnosis of thyroid disease
Blood and urine diagnostic evaluation
Blood and urine samples will be obtained from both case and control groups in order to evaluate EDCs concentrations
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Blood and urine diagnostic evaluation
Blood and urine samples will be obtained from both case and control groups in order to evaluate EDCs concentrations
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* patients without a diagnosis of thyroid cancer will match patients included in arm A
Exclusion Criteria
* patients unable to sign the informed consent or questionnaires
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Istituto Auxologico Italiano
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Istituto Auxologico Italiano, IRCCS
Milan, , Italy
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
05C214
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.